Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Fr Ophtalmol ; 45(9): 1000-1003, 2022 Nov.
Article in French | MEDLINE | ID: mdl-36155145

ABSTRACT

Coronavirus disease 19 (COVID-19) was first observed in Wuhan, China. The disease is caused by a virus (SARS-CoV-2), which spread around the world within a matter of weeks, leading to a large number of deaths. While the health crisis was managed on the ground, the scientific community focused on finding a means to stop it. Vaccine candidates such as the mRNA vaccines (Pfizer BTN162b2 and Moderna mRNA-1273), started to emerge. As these treatments came on the market recently, there is still concern about potential side effects, among them, Herpes Zoster Ophthalmicus (HZO).


Subject(s)
COVID-19 , Herpes Zoster Ophthalmicus , Humans , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy , 2019-nCoV Vaccine mRNA-1273 , BNT162 Vaccine , SARS-CoV-2 , COVID-19/prevention & control , Vaccination/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...